Data & Frameworks
Awards and Initiatives
Awards and Initiatives Menu
Global Initiatives and Memberships
-
Korea Pharmaceutical and Bio-Pharma Manufacturers Association
-
Korea Biotechnology Industry Organization
-
Korea Biomedicine Industry Organization
-
Developing Countries Vaccine Manufactures Network(DCVMN)
-
Task Force on Climate-Related Financial Disclosures(TCFD)
KCGS
A
2023 KCGS Integrated Evaluation
| 연도 | 환경 | 사회 | 거버넌스 |
|---|---|---|---|
| 2022 | A | A+ | A |
| 2023 | B+ | A | A |
With high transparency and expertise, the Korea Corporate Governance Service (KCGS) has been conducting corporate governance assessments since 2003. In 2011, KCGS began assessing ESG management to evaluate sustainability levels of listed companies in South Korea. Its ESG evaluation model not only conforms to international standards such as OECD Principles of Corporate Governance and ISO26000, but also faithfully reflects the domestic legal system and management environment.
MSCI
A
2023 MSCI ESG Ratings
| 연도 | 등급 |
|---|---|
| 2021 | BB |
| 2022 | BBB |
| 2023 | A |
MSCI (Morgan Stanley Capital International), which has been providing ESG evaluation since 1999, evaluates ten topics and thirty-five core issues by ESG area, and gives evaluation results in seven grades from AAA to CCC. A weight is given to the governance evaluation, and in addition to the overall evaluation rating, a separate rating is given for each ESG area.